Featured Publications
Manifestations of Sickle Cell Disorder at Abdominal and Pelvic Imaging.
Solomon N, Segaran N, Badawy M, Elsayes KM, Pellerito JS, Katz DS, Moshiri M, Revzin MV. Manifestations of Sickle Cell Disorder at Abdominal and Pelvic Imaging. RadioGraphics 2022, 42: 1103-1122. PMID: 35559660, DOI: 10.1148/rg.210154.Peer-Reviewed Educational MaterialsConceptsSickle cell disordersMultisystem organ damageCharacteristic clinical syndromeTreatment of patientsPelvic imaging studiesDiagnosis of patientsSickle-shaped red blood cellsEvaluation of manifestationsPelvic manifestationsFunctional aspleniaRed blood cellsClinical presentationOrgan damageOrgan ischemiaSCD complicationsClinical syndromeRecurrent episodesUncommon sequelaVascular occlusionImaging featuresHematologic disordersDisease manifestationsIllness leadCell disordersOnline supplemental material
2025
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts
Baloescu C, Bailitz J, Cheema B, Agarwala R, Jankowski M, Eke O, Liu R, Nomura J, Stolz L, Gargani L, Alkan E, Wellman T, Parajuli N, Marra A, Thomas Y, Patel D, Schraft E, O’Brien J, Moore C, Gottlieb M. Artificial Intelligence–Guided Lung Ultrasound by Nonexperts. JAMA Cardiology 2025, 10: 245-253. PMID: 39813064, PMCID: PMC11904735, DOI: 10.1001/jamacardio.2024.4991.Peer-Reviewed Original ResearchThis study shows AI helps non-experts create expert-quality lung ultrasound images, which may improve healthcare diagnostics access in underserved areas.Acid sphingomyelinase deficiency and Gaucher disease: Underdiagnosed and often treatable causes of hepatomegaly, splenomegaly, and low HDL cholesterol in lean individuals
Mistry P, Cassiman D, Jones S, Lachmann R, Lukina E, Prada C, Wasserstein M, Thurberg B, Foster M, Patel R, Underhill L, Peterschmitt M. Acid sphingomyelinase deficiency and Gaucher disease: Underdiagnosed and often treatable causes of hepatomegaly, splenomegaly, and low HDL cholesterol in lean individuals. Hepatology Communications 2025, 9: e0621. PMID: 39774103, PMCID: PMC11717527, DOI: 10.1097/hc9.0000000000000621.Peer-Reviewed Original ResearchConceptsGaucher disease type 1Acid sphingomyelinase deficiencyHDL cholesterolSphingomyelinase deficiencyDifferential diagnosis of patientsBiomarkers of disease activityLipoprotein phenotypeLower body mass indexMean HDL cholesterolLow HDL cholesterolLiver function testsDiagnosis of patientsBody mass indexModerate hepatosplenomegalySpleen volumeLipid abnormalitiesLow HDLDiagnostic delayIrreversible complicationsLiver volumeLyso-sphingomyelinMultisystemic manifestationsDisease activityLDL cholesterolDifferential diagnosis
2023
Digital Tools for Decision-Making in Coronary Artery Disease
Grubman D, Grubman S, See C, Breen T, Hu J, Altin S. Digital Tools for Decision-Making in Coronary Artery Disease. Current Treatment Options In Cardiovascular Medicine 2023, 25: 737-752. DOI: 10.1007/s11936-023-01022-2.Peer-Reviewed Original ResearchCoronary artery diseaseAcute coronary syndromePercutaneous coronary interventionArtery diseaseRisk stratificationDiagnosis of patientsCoronary syndromeCoronary interventionPoint of carePrimary preventionElectrocardiographic patternCatheterization labClinical uptakeRisk estimation modelCliniciansDiseaseSummaryThe developmentPatientsSyndromeStratificationDiagnosisTriageBiomarkersDigital aidsCare
2020
Identification and Management of Opioid Use Disorder in Primary Care: an Update
Donroe JH, Bhatraju EP, Tsui JI, Edelman EJ. Identification and Management of Opioid Use Disorder in Primary Care: an Update. Current Psychiatry Reports 2020, 22: 23. PMID: 32285215, DOI: 10.1007/s11920-020-01149-0.BooksConceptsOffice-based opioid treatmentOpioid use disorderPrimary care providersUse disordersRecent FindingsThe prevalenceTreatment retention ratesCare of patientsPrimary care practicesDiagnosis of patientsPurpose of ReviewTheFindingsThe prevalenceOpioid treatmentRecent literature pertainingPrimary careComparable outcomesCare providersPatientsCare practicesAmbulatory practiceAddiction medicineCarePrevalenceLiterature pertainingDisordersTreatment
2019
P1528The added value of cardiac magnetic resonance to the diagnosis of patients after aborted sudden cardiac death
Szabo L, Czimbalmos C, Dohy Z, Csecs I, Toth A, Suhai F, Becker D, Geller L, Merkely B, Vago H. P1528The added value of cardiac magnetic resonance to the diagnosis of patients after aborted sudden cardiac death. European Heart Journal 2019, 40: ehz748.0290. DOI: 10.1093/eurheartj/ehz748.0290.Peer-Reviewed Original ResearchCardiac magnetic resonance imagingNormal coronary angiographyLate gadolinium enhancementAborted sudden cardiac deathSudden cardiac deathCardiac magnetic resonance imaging examinationRight ventricular parametersCardiac magnetic resonanceCardiac deathVentricular parametersDiagnostic value of cardiac magnetic resonance imagingPrimary cause of sudden cardiac deathPresence of late gadolinium enhancementDiagnostic valueStructural myocardial abnormalitiesStructural myocardial alterationsCause of sudden cardiac deathLate gadolinium enhancement imagingTask Force criteriaDiagnosis of patientsCoronary artery diseaseStructural alterationsMagnetic resonance imagingConsecutive patientsLV dilatation
2006
Acute renal failure from xanthine nephropathy during management of acute leukemia
LaRosa C, McMullen L, Bakdash S, Ellis D, Krishnamurti L, Wu H, Moritz M. Acute renal failure from xanthine nephropathy during management of acute leukemia. Pediatric Nephrology 2006, 22: 132-135. PMID: 17039332, DOI: 10.1007/s00467-006-0287-z.Peer-Reviewed Original ResearchConceptsTumor lysis syndromeAcute renal failureLysis syndromeXanthine nephropathyRenal failureTumor lysis syndrome prophylaxisOliguric acute renal failureT-cell acute lymphoblastic leukemiaLife-threatening complicationsAcute lymphoblastic leukemiaDiagnosis of patientsAggressive chemotherapyInduction chemotherapyUrinary xanthineUrine alkalinizationSerious complicationsLymphoproliferative malignanciesLymphoblastic leukemiaAcute leukemiaUrine measurementsPreemptive useNephropathyUric acid synthesisSyndromeHypoxanthine levelsThe “Big Dog” Effect: Variability Assessing the Causes of Error in Diagnoses of Patients With Lung Cancer
Raab S, Meier F, Zarbo R, Jensen D, Geisinger K, Booth C, Krishnamurti U, Stone C, Janosky J, Grzybicki D. The “Big Dog” Effect: Variability Assessing the Causes of Error in Diagnoses of Patients With Lung Cancer. Journal Of Clinical Oncology 2006, 24: 2808-2814. PMID: 16782918, DOI: 10.1200/jco.2005.04.3661.Peer-Reviewed Original ResearchConceptsKappa statisticsQuality improvement interventionsDiagnosis of patientsFalse-negative diagnosesInstitutional pathologistsLung massSurgical specimenLung cancerPathology specimenPulmonary specimensReview diagnosisSlide reviewPatientsImprovement interventionsOriginal diagnosisInter-pathologist agreementPsychosocial hypothesesClinical samplingDiagnosisInterobserver agreementCancer diagnosisDiagnostic samplesInitial assessmentSame institutionDiagnostic errors
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply